Hbk Investments L P Amgen Inc Transaction History

Hbk Investments L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $117,877 - $151,513	-623 Reduced 3.74%	16,033 $3.87 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $1.25 Million - $1.5 Million	7,194 Added 76.03%	16,656 $3.22 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $21.7 Million - $25.5 Million	-130,384 Reduced 93.23%	9,462 $1.74 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $21.6 Million - $24.3 Million	119,248 Added 578.93%	139,846 $26.6 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $3.04 Million - $3.43 Million	16,398 Added 390.43%	20,598 $4.27 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $372,746 - $435,600	2,200 Added 110.0%	4,200 $716,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $337,580 - $377,180	2,000	2,000 $348,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.